Related references
Note: Only part of the references are listed.2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease
Brian A. Ference et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Residual Cardiovascular Risk in Statin-Treated Patients with Elevated Triglycerides: Now We Can REDUCE-IT!
Deepak L. Bhatt
EUROPEAN HEART JOURNAL (2019)
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association
Ann C. Skulas-Ray et al.
CIRCULATION (2019)
Cardiovascular risk reduction with icosapent ethyl
Parth N. Patel et al.
CURRENT OPINION IN CARDIOLOGY (2019)
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Carl E. Orringer et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2019)
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Deepak L. Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Rationale and design of REDUCE-IT: Reduction of Cardiovascular Events with Icosapent Ethyl-Intervention Trial
Deepak L. Bhatt et al.
CLINICAL CARDIOLOGY (2017)
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)
Marco Metra et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Minicharged particles from the Sun: a cutting-edge bound
N. Vinyoles et al.
JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS (2016)
The Anatomy of Medical Research US and International Comparisons
Hamilton Moses et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Marc A. Pfeffer et al.
CIRCULATION (2015)
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry
Sabrina Bernardez-Pereira et al.
AMERICAN HEART JOURNAL (2014)
International differences in treatment effect: do they really exist and why?
Stuart Pocock et al.
EUROPEAN HEART JOURNAL (2013)
Are All Clinical Trial Sites Created Equal?
Deepak L. Bhatt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-Mill trial
Patrick Tobbia et al.
EUROINTERVENTION (2013)
Safety and efficacy of prasugrel compared with clopidogrel in different regions of the world
Christian T. Ruff et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Exact spherically-symmetric inhomogeneous model with n perfect fluids
Valerio Marra et al.
JOURNAL OF COSMOLOGY AND ASTROPARTICLE PHYSICS (2012)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
